Skip to main content

Table 1 Baseline characteristics of a cohort from general population in Xiamen

From: Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera

Group

n (%)

HSV-1 seroprevalence (%)

HSV-1 NAb prevalence (%)

Average NAb titers (log2NT50)

Age (years)

   

≤10

41 (15.2 %)

29.3 % (17.6 %-44.5 %)*

31.7 % (19.6 %-47.0 %)*

4.4 ± 3.1

11-20

47 (17.5 %)

74.5 % (60.5 %-84.8 %)*

74.5 % (60.5 %-84.8 %)*

7.5 ± 3.1

21-30

41 (15.2 %)

92.7 % (80.6 %-97.5 %)

95.1 % (83.9 %-98.7 %)

9.2 ± 1.6

31-40

49 (18.2 %)

91.8 % (80.8 %-96.8 %)

97.9 % (89.3 %-99.6 %)

9.1 ± 1.4

41-50

48 (17.8 %)

91.7 % (80.5 %-96.87 %)

97.9 % (89.1 %-99.6 %)

9.5 ± 1.7

>50

43 (16.0)

97.7 % (87.9 %-99.6 %)

100 % (91.8 %-100 %)

9.8 ± 1.6

Gender

    

Male

126 (46.8 %)

83.3 % (75.9 %-88.8 %)

84.9 % (77.7 %-90.1 %)

8.2 ± 2.8

Female

143 (53.2 %)

76.9 % (69.4 %-83.1 %)

82.5 % (75.5 %-87.9 %)

8.4 ± 2.9

Total

269

79.9 % (74.7 %-84.3 %)

83.6 % (78.8 %-87.6 %)

8.3 ± 2.8

  1. *p < 0.05; 95 % confidence interval shown in brackets